CONFERENCE UPDATE : EULAR 2020

The latest guidelines on the pharmacological treatment of psoriatic arthritis

01 Sep 2020

EULAR has published an updated version of the recommendations on treating psoriatic arthritis (PsA). The objective of the update is to include new PsA drugs.

On behalf of the EULAR PsA Management Taskforce, Dr. Laure Gossec, MD, Ph.D., a Professor of Rheumatology in Pitie-Salpetriere Hospital, Pierre and Marie Curie University (Paris 06 University), Paris, France, presented the new 2019 EULAR recommendations on the pharmacological treatment of PsA at the EULAR 2020 e-congress.


References
  1. Gossec L et al. The EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Annals of the Rheumatic Diseases 2020.
  2. Kerschbaumer A et al. Pharmacological treatment of psoriatic arthritis: systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis. Ann Rheum Dis 2016
GUIDANCE
PSORIATIC ARTHRITIS
2019 EULAR RECOMMENDATIONS
DISEASE-MODIFYING ANTIRHEUMATIC DRUGS